SB 0917 Mandates insurance coverage for new phases of clinical trials undertaken for the treatment of cancer
Sponsor:Dougherty Co-Sponsor(s)
LR Number:2779S.01I Fiscal Note:2779-01
Committee:Small Business, Insurance & Industrial Relations
Last Action:01/15/04 - Second Read and Referred S Small Business, Insurance Journal page:S117
and Industrial Relations Committee
Effective Date:August 28, 2004
Full Bill Text | All Actions | Available Summaries | Senate Home Page | List of 2004 Senate Bills
Current Bill Summary

SB 917 - This act requires health insurance companies to provide coverage for routine patient care costs incurred as the result of phase I or II clinical trials undertaken to treat cancer. Currently, Section 376.429, RSMo, requires coverage for phases III or IV only.